HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators.

AbstractINTRODUCTION:
The coronavirus disease 2019 (COVID-19) has quickly become a global threat to public health, and it is difficult to predict severe patients and their prognosis. Here, we intended developing effective models for the late identification of patients at disease progression and outcome.
METHODS:
A total of 197 patients were included with a 20-day median follow-up time. We first developed a nomogram for disease severity discrimination, then created a prognostic nomogram for severe patients.
RESULTS:
In total, 40.6% of patients were severe and 59.4% were non-severe. The multivariate logistic analysis indicated that IgG, neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase, platelet, albumin, and blood urea nitrogen were significant factors associated with the severity of COVID-19. Using immune response phenotyping based on NLR and IgG level, the logistic model showed patients with the NLRhi IgGhi phenotype are most likely to have severe disease, especially compared to those with the NLRlo IgGlo phenotype. The C-indices of the two discriminative nomograms were 0.86 and 0.87, respectively, which indicated sufficient discriminative power. As for predicting clinical outcomes for severe patients, IgG, NLR, age, lactate dehydrogenase, platelet, monocytes, and procalcitonin were significant predictors. The prognosis of severe patients with the NLRhi IgGhi phenotype was significantly worse than the NLRlo IgGhi group. The two prognostic nomograms also showed good performance in estimating the risk of progression.
CONCLUSIONS:
The present nomogram models are useful to identify COVID-19 patients with disease progression based on individual characteristics and immune response-related indicators. Patients at high risk for severe illness and poor outcomes from COVID-19 should be managed with intensive supportive care and appropriate therapeutic strategies.
AuthorsFang Tang, Xiaoshuai Zhang, Bicheng Zhang, Bo Zhu, Jun Wang
JournalJournal of medical virology (J Med Virol) Vol. 94 Issue 1 Pg. 131-140 (01 2022) ISSN: 1096-9071 [Electronic] United States
PMID34403145 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 Wiley Periodicals LLC.
Chemical References
  • Immunoglobulin G
Topics
  • Aged
  • COVID-19 (diagnosis, immunology, physiopathology)
  • Disease Progression
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Leukocyte Count
  • Lymphocytes
  • Male
  • Middle Aged
  • Neutrophils
  • Nomograms
  • Prognosis
  • Retrospective Studies
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: